A detailed history of Foresite Capital Opportunity Management V, LLC transactions in Gemini Therapeutics, Inc. stock. As of the latest transaction made, Foresite Capital Opportunity Management V, LLC holds 2,435,125 shares of GMTX stock, worth $59.3 Million. This represents 11.99% of its overall portfolio holdings.

Number of Shares
2,435,125
Previous 2,435,125 -0.0%
Holding current value
$59.3 Million
Previous $4.12 Million 2.94%
% of portfolio
11.99%
Previous 10.37%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

BUY
$2.39 - $4.0 $5.82 Million - $9.74 Million
2,435,125 New
2,435,125 $7.09 Million

Others Institutions Holding GMTX

# of Institutions
1
Shares Held
2.44M
Call Options Held
0
Put Options Held
0

About Gemini Therapeutics, Inc.


  • Ticker GMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,244,500
  • Market Cap $1.05B
  • Description
  • Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 ...
More about GMTX
Track This Portfolio

Track Foresite Capital Opportunity Management V, LLC Portfolio

Follow Foresite Capital Opportunity Management V, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Opportunity Management V, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Opportunity Management V, LLC with notifications on news.